Friday, August 22, 2014

European Medicines Agency Accepts Basilea's Isavuconazole Marketing …

Basilea Pharmaceutica Ltd. (SIX: BSLN) announces that the European Medicines Agency (EMA) has accepted its isavuconazole Marketing Authorization Application (MAA) for review. Basilea's MAA seeks approval of isavuconazole for the treatment of invasive aspergillosis and mucormycosis (zygomycosis) in adults. More …

Friday, August 22, 2014

Scientists Learn More About Rare Skin Cancer That Killed Bob Marley

Cancer Research UK scientists have discovered that acral melanomas – the rare type of skin cancer that caused reggae musician Bob Marley’s death – are genetically distinct from other more common types of skin cancer, according to a study published in the journal Pigment Cell & Melanoma Research. More …